COMPANY
Solius
Funding and NIH signals
- SEC Form D raise Raised $3.5M (Form D filed May 14, 2026); +1 other Form D filing in the last 12 months. SEC Form D 0001537914-26-000003 (May 14, 2026)
Evidence (2 events)
- May 14, 2026 · SEC Form D 0001537914-26-000003
Name of Issuer: Solius Labs, Inc.; CIK: 1537914; Address: Bainbridge Island, WA; Submission type: D; Filing date: 2026-05-14; Industry Group: Other Health Care; Date of First Sale: 2026-04-29; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 17911021; Total Amount Sold: 3500000; Federal exemptions: 06b - May 14, 2026 · SEC Form D 0001537914-26-000002
Name of Issuer: Solius Labs, Inc.; CIK: 1537914; Address: Bainbridge Island, WA; Submission type: D; Filing date: 2026-05-14; Industry Group: Other Health Care; Date of First Sale: 2023-03-14; Types of Securities Offered: Equity, Other (Security to be Acquired upon Conversion); Business combination transaction: false; Total Offering Amount: 23493691; Total Amount Sold: 23493691; Federal exemptions: 06b
- May 14, 2026 · SEC Form D 0001537914-26-000003
Timeline
- FDA FDA 510(k) clearance: SOLIUS PRO UVB Light Panel — K252960, Jan 16, 2026. Applicant at approval: Solius Labs, Inc. source ↗
FDA records (last 2 years)
- FDA 510(k) clearance: SOLIUS PRO UVB Light Panel — K252960, Jan 16, 2026. Applicant at approval: Solius Labs, Inc. source ↗
Connect
See your connections at Solius on LinkedIn (search by name, results not checked)